Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012 PowerPoint presentation | free to download - id: 7216c4-MGJlO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012

Description:

Global Markets Directs, “Premature Labor (Tocolysis) Pipeline Review”, H1 2014, provides an overview of the Premature Labor (Tocolysis)s therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:6
Slides: 12
Provided by: addyparker2350
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Premature Labor (Tocolysis) Pipeline Review, H1 2012


1
Aarkstore - Premature Labor (Tocolysis) Pipeline
Review, H1 2012
www.aarkstore.com
2
Summary
  • Global Markets Directs, Premature Labor
    (Tocolysis) Pipeline Review, H1 2014,
  • Provides an overview of the Premature Labor
    (Tocolysis)s therapeutic pipeline.
  •  
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Premature Labor (Tocolysis),
    complete with comparative analysis at various
  • stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
  • Premature Labor (Tocolysis) and special features
    on late-stage and discontinued projects.

www.aarkstore.com
3
Scope
  • The report provides a snapshot of the global
    therapeutic landscape of Premature Labor
    (Tocolysis)
  • The report reviews key pipeline products under
    drug profile section which includes, product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities
  • The report reviews key players involved in the
    therapeutics development for Premature Labor
    (Tocolysis) and enlists all their major and minor
    projects
  • The report summarizes all the dormant and
    discontinued pipeline projects
  • A review of the Premature Labor (Tocolysis)
    products under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources
  • Pipeline products coverage based on various
    stages of development ranging from
    pre-registration till discovery and undisclosed
    stages

www.aarkstore.com
4
Reasons to buy
  • Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies
  • Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding
    the focus areas of leading companies
  • Identify and understand important and diverse
    types of therapeutics under development for
    Premature Labor (Tocolysis)
  • Plan mergers and acquisitions effectively by
    identifying key players of the most promising
    pipeline
  • Devise corrective measures for pipeline projects
    by understanding Premature Labor (Tocolysis)
    pipeline depth and focus of Indication
    therapeutics
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and Scope

www.aarkstore.com
5
Table of Contents
  • Introduction 5
  • Global Markets Direct Report Coverage 5
  • Premature Labor (Tocolysis) Overview 6
  • Therapeutics Development 7
  • Pipeline Products for Premature Labor (Tocolysis)
    - Overview 7
  • Pipeline Products for Premature Labor (Tocolysis)
    - Comparative Analysis 8
  • Premature Labor (Tocolysis) - Therapeutics under
    Development by Companies 9
  • Premature Labor (Tocolysis) - Pipeline Products
    Glance 10
  • Clinical Stage Products 10
  • Premature Labor (Tocolysis) - Products under
    Development by Companies 11
  • Premature Labor (Tocolysis) - Companies Involved
    in Therapeutics Development 12
  • GlaxoSmithKline plc 12
  • Actavis plc 13

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Premature Labor (Tocolysis), H1 2014 7
  • Number of Products under Development for
    Premature Labor (Tocolysis) - Comparative
    Analysis, H1 2014 8
  • Number of Products under Development by
    Companies, H1 2014 9
  • Comparative Analysis by Clinical Stage
    Development, H1 2014 10
  • Products under Development by Companies, H1 2014
    11
  • Premature Labor (Tocolysis) - Pipeline by
    GlaxoSmithKline plc, H1 2014 12
  • Premature Labor (Tocolysis) - Pipeline by Actavis
    plc, H1 2014 13
  • Premature Labor (Tocolysis) - Pipeline by Kissei
    Pharmaceutical Co., Ltd., H1 2014 14
  • Premature Labor (Tocolysis) - Pipeline by PDC
    Biotech GmbH, H1 2014 15
  • Premature Labor (Tocolysis) - Pipeline by Ferring
    Pharmaceuticals, Inc., H1 2014 16

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Premature Labor (Tocolysis), H1 2014 7
  • Number of Products under Development for
    Premature Labor (Tocolysis) - Comparative
    Analysis, H1 2014 8
  • Number of Products under Development by
    Companies, H1 2014 9
  • Comparative Analysis by Clinical Stage
    Development, H1 2014 10
  • Assessment by Monotherapy Products, H1 2014 17
  • Number of Products by Top 10 Target, H1 2014 18
  • Number of Products by Stage and Top 10 Target, H1
    2014 19
  • Number of Products by Top 10 Mechanism of Action,
    H1 2014 20
  • Number of Products by Stage and Top 10 Mechanism
    of Action, H1 2014 21
  • Number of Products by Top 10 Route of
    Administration, H1 2014 22

www.aarkstore.com
8
Related Market Research reports
  • Alpha- Antitrypsin Deficiency - Pipeline Review,
    H1 2015
  •  
  • Hyperphosphatemia - Pipeline Review, H1 2015
  •  
  • H3N2 Infection - Pipeline Review, H1 2015 
  • Cough - Pipeline Review, H1 2015
  •  
  • Alopecia - Pipeline Review, H1 2015

www.aarkstore.com
9
Related Market Research reports
  • Anthrax - Pipeline Review, H1 2015
  • Degenerative Disc Disease - Pipeline Review, H1
    2015
  • Male Infertility - Pipeline Review, H1 2015
  •  
  • Women Infertility - Pipeline Review, H1 2015
  •  
  • Nasopharyngeal Cancer - Pipeline Review, H1 2015

www.aarkstore.com
10
Aarkstore - Premature Labor (Tocolysis) Pipeline
Review, H1 2012
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com